| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 36 |
| 1 | BEVACIZUMAB | 33 |
| 2 | PACLITAXEL | 30 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 30 |
| 4 | CARBOPLATIN | 27 |
| 5 | FLUOROURACIL | 21 |
| 6 | FLUOROURACIL CREAM, 0.5% | 21 |
| 7 | DOCETAXEL | 16 |
| 8 | DOCETAXEL ANHYDROUS | 16 |
| 9 | PEMBROLIZUMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILTUXIMAB | 1 | 0.0015 |
| 1 | TOPICAL ANESTHETIC | 1 | 0.0012 |
| 2 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 3 | RAMUCIRUMAB | 7 | 0.0011 |
| 4 | BENZOCAINE | 1 | 0.0010 |
| 5 | CISPLATIN | 36 | 0.0005 |
| 6 | CODEINE SULFATE | 1 | 0.0003 |
| 7 | PACLITAXEL | 30 | 0.0003 |
| 8 | DEXAMETHASONE SODIUM PHOSPHATE | 3 | 0.0003 |
| 9 | FLUOROURACIL CREAM, 0.5% | 21 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 7 | 0.0011 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 28 | 0.0003 |
| 3 | Microtubule Inhibitor [EPC] | 45 | 0.0003 |
| 4 | Platinum-based Drug [EPC] | 73 | 0.0003 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 34 | 0.0002 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 24 | 0.0001 |